In our past webinar, “How Dashboards Drive ICH E6(R2) Compliance,” we explained how a sponsor with multiple CROs managed complexity, risk, and productivity along their path to ICH E6(R2) compliance.
This mid-market pharmaceutical company, with $800M in revenue and more than 1,000 employees, was managing eight studies with a small internal team and had two more studies in the wings. What’s more, the company’s trials were growing in complexity. Procedures per protocol were increasing by more than 50%. All of the trials were global. And a recent acquisition added a whole new set of data systems to the mix. Faced with these issues, the study team brought on a third CRO to help meet their clinical trial milestones.